Previous 10 | Next 10 |
Inovio Pharmaceuticals press release ( NASDAQ: INO ): FY GAAP EPS of -$1.17 misses by $0.06 . Revenue of $10.26M (+479.7% Y/Y) misses by $0.29M . For further details see: Inovio Pharmaceuticals GAAP EPS of -$1.17 misses by $0.06, revenue of $10.26M misses by $0.29M
INOVIO Reports Fourth Quarter and Full Year 2022 Financial Results and Clinical Highlights PR Newswire Announces topline results from REVEAL2, the second Phase 3 trial evaluating VGX-3100 as a treatment for cervical high-grade squamous intraepithelial lesions (HSIL) Tria...
FWA business up 122% year-over-year, making up 30% of revenue Cloud software up 6% year-over-year, making up 27% of revenue Gross margin expands to 30% on continued ramp in FWA and cloud software revenues Inseego Corp. (Nasdaq: INSG) (the “Company”), a lead...
Inovio Pharmaceuticals ( NASDAQ: INO ) is scheduled to announce FY earnings results on Wednesday, March 1st, after market close. The consensus EPS Estimate is -$1.13 (+22.1% Y/Y) and the consensus Revenue Estimate is $10.55M (+496.0% Y/Y). Over the last 1 year, INO has beate...
Palm Beach, FL – February 28, 2023 – FinancialNewsMedia.com News Commentary – The Coronavirus Global Market has been growing in the past few years and is anticipated to continue to grow in the next several years. In fact, the whole vaccines market is project...
INOVIO Announces Positive Preliminary Results from Second Cohort of Phase 1/2 Trial with INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis PR Newswire 10 of 11 patients (91%) had a reduction in number of surgical interventions, measured from Day 0 to one year ...
INOVIO to Report Fourth Quarter and Year-End 2022 Financial Results on March 1, 2023 PR Newswire PLYMOUTH MEETING, Pa. , Feb. 15, 2023 /PRNewswire/ -- INOVIO ( NASDAQ : INO ), a biotechnology company focused on developing and commercializing DNA medicin...
Inseego Corp. (Nasdaq: INSG), a leader in 5G edge cloud solutions, will release financial results for the quarter and year ended December 31, 2022 after the stock market close on Wednesday, March 1, 2023. Inseego will host a webcast and conference call for analysts and investors at 5:00 p.m. ...
3 Reasons to Buy Penny Stocks in February 2023 Penny stocks refer to low-priced, highly speculative securities that trade for less than $5 per share. Despite their reputation as a high-risk investment, buying penny stocks can offer several benefits to investors. One of the main benefits of ...
INOVIO Reports Positive Phase 1b Results for INO-4201 as an Ebola Booster for rVSV-ZEBOV (Ervebo®) PR Newswire INO-4201 found to be well-tolerated in the trial Humoral responses were boosted in 100% (36 of 36) of treated participants PLYMOUTH MEETING, Pa. ...
News, Short Squeeze, Breakout and More Instantly...
Inovio Pharmaceuticals Inc. Company Name:
INO Stock Symbol:
NASDAQ Market:
Inovio Pharmaceuticals Inc. Website:
5G leader welcomes new Chief Product Officer, Senior Vice President Sales/Service Providers and Head of Operations Inseego Corp. (Nasdaq: INSG), a technology leader in 5G mobile and fixed wireless solutions for mobile network operators, Fortune 500 enterprises, and SMBs, today announced...
2024-07-16 13:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Inseego Corp. (Nasdaq: INSG), a technology leader in 5G mobile and fixed wireless solutions for mobile network operators, Fortune 500 enterprises and SMBs, today announced that the company will release its financial results for the second quarter of 2024, ended June 30, 2024, after the financial ...